Jyong Biotech, a biotech company based in Taiwan, has noticed some unusual activity in its stock price and trading volume. This comes just after a lock-up period ended this month. The company is in talks with some investment funds about buying shares, but they say they're not hiding any big news tha
Tom Brady, the famous NFL player, surprised everyone with a big announcement. His new dog, Junie, is actually a clone of his late dog, Lua. This wasn't just any pet project; it was made possible by Colossal Biosciences, a company that Brady invests in. The news came out on November 4, 2025, and it g
Mural Oncology plc, a biotech firm based in Waltham, is undergoing a major overhaul. The company has decided to halt the development of its primary cancer treatment, nemvaleukin. This move is part of a broader strategy to explore new directions for the firm. The decision to stop developing nemvaleu
Bluebird Bio, once a shining star in the biotech world, is now a shadow of its former self. The company, known for its groundbreaking gene therapies, has been sold to private equity firms Carlyle and SK Capital for a mere $30 million. This sale marks the end of a long and tumultuous journey for Blue
